Diabetics on Januvia, Byetta at risk for dangerous pancreatic inflammation, researchers find

Share this article:
People who take diabetes medications Januvia and Byetta are at a significantly elevated risk of a painful and potentially dangerous pancreatic inflammation, according to a recently published study.

Johns Hopkins University School of Medicine researchers looked at 1,269 people who took at least one prescription diabetes drug between 2005-2008, comparing them to a control group of 1,269 diabetics who did not take a prescription drug to treat the condition during that period.

People who took glucagon-like peptide-1-based drugs such as Januvia and Byetta were twice as likely as other diabetics of being hospitalized with pancreatitis within 60 days of starting a course of drug treatment.

Pancreatitis is inflammation of the pancreas that can be fatal if left untreated. The millions of patients on Januvia and Byetta means long-term care providers should be alert to the symptoms of pancreatitis, the researchers cautioned. Symptoms include abdominal pain, nausea and persistent vomiting.

The study results appear in the online edition of the journal JAMA Internal Medicine.

Share this article:

More in News

Skilled nursing facilities with poor quality ratings do not readmit more patients to hospitals, researchers find

Skilled nursing facilities with poor quality ratings do ...

Low-quality and high-quality skilled nursing facilities readmit about the same proportion of residents to hospitals, suggest research findings recently published in the American Journal of Medical Quality.

Cipro and related antibiotics increase MRSA risk in long-term care facilities, study ...

Long-term care residents on a fluoroquinolone antibiotic such as Cipro are at an increased risk for methicillin-resistant Staphylococcus aureus, researchers in France have found.

Jonathan Blum, who oversaw long-term care reforms, resigns as head of Medicare

The nation's top Medicare official, Jonathan Blum, is leaving his post next month, news outlets reported Tuesday. Blum became a familiar figure to long-term care providers through Open Door Forum calls and other outreach efforts during his five-year tenure, as he guided implementation of Medicare ...